Novel vaccine raises hope for total immunity from malaria

08/9/2013 | CNET

An intravenous malaria vaccine was found effective in a small clinical trial. Maryland-based biotech company Sanaria developed the PfSPZ vaccine made from sporozoites, an immature stage of malarial parasite Plasmodium falciparum. A study in the journal Science reported that among the 15 participants who were administered high doses of the vaccine, 12 have shown complete immunity from the infectious disease. However, administering the intravenous vaccine may be challenging in a larger scale, compared with injected and oral vaccine that are given promptly.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Master Educator
DC Public Schools
Washington, DC
District Superintendent
Department of Defense Education Activity (DoDEA)
Partner - Strategy, Systems and Policy
Nationwide, SL_Nationwide
Professional Development Manager (West Coast residence preferred)
Rowland Reading Foundation
Nationwide, SL_Nationwide
Deputy Director for Curriculum, Instruction & Assessment
Department of Defense Education Activity (DoDEA)